Exocell Inc.

Click Here To EMAIL INQUIRY
Contact: Dr. Gregory Lautenslager - QA & QC Manager
Web: http://www.exocell.com
E-Mail:
Address: 1880 JFK Boulevard, Suite 200, Philadelphia, Pennsylvania 19103, USA
Phone: +1-(215)-557-8021, 800-234-3962 | Fax: +1-(215)-557-8053 | Map/Directions >>

Profile: Exocell focuses on developing, marketing & performing clinical & investigative diagnostic assays that aid basic science investigations and experimental animal & clinical research concerning diagnosis & treatment of diabetes & associated kidney & vascular diseases. We offer products and assays that encompass clinical diagnostics, clinical investigation, laboratory research, reagents and reference standards. Our Albuwell assay kits are used to measure microalbuminuria, a marker of early diabetic kidney dysfunction. Our Glycaben assay is used to monitor glycated albumin, the index of intermediate term glycemic control.

The company was founded in 1988, has revenues of USD 1-5 Million, has ~20 employees.

5 Products/Services (Click for related suppliers)

• Albumin Antigen Antiserum Control (FDA Code: DCF / 866.5040)

An albumin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the albumin (a plasma protein) in serum and other body fluids. Measurement of albumin aids in the diagnosis of kidney and intestinal diseases.

• Clinical Colorimeter (FDA Code: JJQ / 862.2300)

A colorimeter, a photometer, or a spectrophotometer for clinical use is an instrument intended to measure radiant energy emitted, transmitted, absorbed, or reflected under controlled conditions. The device may include a monochromator to produce light of a specific wavelength.

• Clinical Diagnostic Immunoassay Products

• Glycosylated Hemoglobin Assay Test (FDA Code: LCP / 864.7470)

A glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient.

• Urinary Protein/Albumin Nonquantitative Test System (FDA Code: JIR / 862.1645)

A urinary protein or albumin (nonquantitative) test system is a device intended to identify proteins or albumin in urine. Identification of urinary protein or albumin (nonquantitative) is used in the diagnosis and treatment of disease conditions such as renal or heart diseases or thyroid disorders, which are characterized by proteinuria or albuminuria.